The elritercept Phase 3 RENEW clinical trial (NCT06499285) is a global, randomized, double-blind, placebo-controlled trial in ...

Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients, ...

Myelodysplastic syndromes are diseases of older patients. The median age in the United States is 76 years old, meaning that most of your patients are going to be in their eighth decade of life, ...

Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does ...

Dr. Mika Kontro, MD, PhD, will deliver a presentation titled "Efficacy of Macrophage Checkpoint Clever-1 Inhibition with ...

In this study, we set out to evaluate the frequency of mutations in 20 myelodysplastic syndrome-associated genes in 53 individuals with pancytopenia in which bone marrow evaluation failed to meet ...

Some cancer treatments raise the risk of myelodysplastic syndromes. June 12, 2012— -- Jenna Langer was a high school senior when she was diagnosed with osteosarcoma, the most common form of ...

"Good Morning America" anchor Robert Roberts shared news today that she's facing a serious new health challenge: MDS or myelodysplastic syndrome. Dr. Richard Besser explains what MDS is and the ...

A. Myelodysplastic syndrome, or MDS, is a cancer of the bone marrow involving the stem cells that make up our blood — red blood cells, white blood cells and platelets. It is typically a slow ...

It took a misplaced elbow, a quirk of Los Angeles geography and some whistling from his wife to produce one of television’s ...